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MEETING REVIEW
On human development: lessons from stem cell systems
Alexander Medvinsky1,* and Frederick J. Livesey2
ABSTRACT
In September 2014, over 100 scientists from around the globe
gathered at Wotton House near London for the Company of
Biologists’ workshop ‘From Stem Cells to Human Development’.
The workshop covered diverse aspects of human development, from
the earliest stages of embryogenesis to differentiation of mature cell
types of all three germ layers from pluripotent cells. In this Meeting
Review, we summarise some of the exciting data presented at the
workshop and draw together the main themes that emerged.
KEY WORDS: Directed differentiation, Embryogenesis, Embryonic
stem cells, Human development, Pluripotent stem cells
Introduction
For four days in late September 2014, the beautiful venue of Wotton
House, Dorking, UK, played host to the Company of Biologists’
workshop ‘From Stem Cells to Human Development’. For this
exciting workshop, the organisers Olivier Pourquié, Benoit
Bruneau and Austin Smith (all editors of this journal) brought
together leading scientists from around the world with a common
interest in understanding human development using stem cell
systems. The objective of the meeting was to explore how the early
human embryo is organised, how diverse cell lineages emerge and
mature to form organs and tissues, and how we can carry out
mechanistic studies of these processes using stem cell systems. The
workshop also considered what happens when these developmental
processes go wrong in disease states and how they can be corrected.
Ethical questions posed by work with human stem cells and their
derivatives were an important theme of the meeting, detailed
elsewhere in this issue (Hermerén, 2015; Hyun, 2015). Tributes
were paid to a pioneer in field, Yoshiki Sasai, who was scheduled to
speak at the meeting, and whose recent loss has been deeply felt by
his friends and colleagues.
The programme of the meeting was carefully crafted to explore
how understanding embryonic development and pluripotent stem
cell (PSC) biology have mutually benefited each other. Many
presentations demonstrated a remarkable convergence of these two
research topics in recent years, stimulated both by fundamental
biological and applied, translational research questions. In this
Meeting Review, we describe exciting findings presented by the
speakers and summarise some of the main themes that emerged
from the various presentations. We apologise that due to space
limitations not all talks are mentioned directly.
Stem cells: pluripotent states and preimplantation human
development
The meeting started with discussions of the earliest stages of human
and mouse preimplantation development, and their relationship
with different types of embryonic stem cells (ESCs). Pluripotency is
a key property of ESCs. However, it is becoming increasingly clear
that pluripotency is not a single state: stem cells persist in the inner
cell mass from the preimplantation stage through to gastrulation,
which lasts for 3 days in mouse and much longer in human. Naïve
stem cells change their properties and become primed for
differentiation when they are closer to exit from pluripotency.
Human ESCs derived from blastocysts are closer to primed than
naïve mouse ESCs and it is important to understand why this is. To
address this issue, Austin Smith (Cambridge Stem Cell Institute,
UK) and colleagues expressed NANOG and KLF2, two factors that
define naïve status in mouse ESCs, in human ESCs, and treated them
with a PKC inhibitor (known to block mouse ESC differentiation).
These cells showed stable naïve-like status (Takashima et al., 2014).
Such ‘reset’ pluripotent cell linesmaintain normal karyotype and can
make teratomas; metabolically, transcriptionally and by genome-
wide hypomethylation, they closely resemble mouse naïve ESCs. In
agreement with these findings, Jennifer Nichols (Cambridge Stem
Cell Institute, UK) described human ESCs as slowly growing,
poorly clonogenic cells, which express markers of postimplantation
embryos. She emphasised how our understanding of the human
naïve pluripotent state can be informed by mouse studies: given that
in the human embryo the early segregation of naïve epiblast and
primitive endoderm occurs in a similar fashion as in the mouse, why
is it so difficult to derive naïve cells from human?
Susan Fisher (University of California San Francisco, USA)
described considerable morphological diversity of blastomeres from
very early stages of human development and successful derivation
of human ESCs from individual blastomeres. Blastomeres of a
single eight-cell embryo yielded karyotypically normal, highly
hypomethylated pluripotent cell lines. Bioinformatics analysis
showed that these cell lines clustered away from conventional
human ESCs and differed from each other, even if derived from the
same embryo. The capacity of these cells to make teratomas and to
differentiate to trophoblast cells suggests that these cells are
totipotent.
The importance of intercellular signalling in blastocyst development
and its relevance for ES cell derivation was also a theme of Janet
Rossant’s (Hospital for Sick Children, Toronto, Canada) presentation:
using live imaging of fluorescent reporter mice, her lab has studied the
timing of commitment to pluripotency versus trophectoderm
formation and has shown the importance of components of the
Hippo signalling pathway in this process. The timing of lineage
commitment in the human blastocyst appears to be later than in the
mouse and it is currently unclearwhether the same signalling pathways
are involved. Joanna Wysocka (Stanford University, USA) also
emphasised the need for a greater understanding of the biology of
human preimplantation development, given the striking activation of
primate- and human-specific endogenous retroviral elements that she
and her colleagues are studying at those stages of development.
A powerful approach for mechanistic studies of the earliest steps
in human preimplantation development was described by Ali
Brivanlou (Rockefeller University, New York, USA) in his
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presentation on self-organisation and patterning of human ESCs in
culture. By using micropatterned substrates to standardise ESC
colony size and shape, his lab, in collaboration with Eric Siggia
(Rockefeller University, New York, USA), has demonstrated highly
reproducible spatial patterns of differentiation in response to BMP4
(Warmflash et al., 2014). The process of establishing patterns can be
tracked in real time using reporter lines, and gastrulation-like
movements could be observed, providing high-content data for
computational biology studies.
Haematopoiesis: from mouse to human and back again
A number of presentations addressed different aspects of the
challenging problem of studying human haematopoiesis in vitro,
and how we can learn from work in model systems. Alexander
Medvinsky (MRC Centre for Regenerative Medicine, Edinburgh,
UK) discussed the development of adult haematopoietic stem cells
(HSC), emphasising that differentiation of ESCs can generate
various haematopoietic cell types but not HSCs. His lab is studying
mechanisms of HSC formation in the mouse embryo and models
this process in culture. Analysis of mouse allowed testing main
principles of HSC development in human embryos (Ivanovs et al.,
2014). In a related talk, Elaine Dzierzak (MRC Centre for
Inflammation Research, Edinburgh, UK) provided insights into
the organisation of intra-aortic clusters and their role in the
production of HSCs. Combining specific reporter mice to
visualise HSC formation in a model culture system, with tracking
of populations preceding HSC formation, her lab has analysed their
gene expression profiles to identify transcription factors potentially
involved in early developmental specification of HSCs.
Gordon Keller (McEwen Centre for Regenerative Medicine,
Toronto, Canada) argued that, if we want to recapitulate
development of different mesodermal derivatives in vitro from
pluripotent cells, manipulation of duration and concentration of
factors is likely to be required. He addressed the difficulties in
producing true, clinically relevant HSCs from human ESCs and
described his strategy to achieve this goal (Kennedy et al., 2012;
Sturgeon et al., 2014). Keller underscored that the haematopoietic
lineage is segregated from the mesoderm at very early stages of
embryogenesis, and that this must be taken into account for in vitro
ESC differentiation protocols. His lab has made notable progress in
manipulating signalling during ESC differentiation down the HSC
route and in identifying cell fractions that give rise to primitive and
definitive types of haematopoiesis.
Extending the haematopoiesis theme, Cedric Ghevaert
(University of Cambridge, UK) discussed approaches to generate
significant amounts of platelets from induced pluripotent stem cells
(iPSCs) for transfusion in humans under Good Manufacturing
Practice-compatible conditions. Two main issues have to be
addressed: efficient production of megakaryocytes (MKs) and
efficient platelet release from MKs. He showed that enforced
expression in iPSCs of three transcription factors (TAL1, GATA1,
FLI1) generates a population of MK precursors that can be
maintained in culture for a long period of time (120 days) and that
produce mature MKs similar to their primary counterparts. His
group is actively working on the problem of platelet release in
functionalised three-dimensional (3D) collagen-based scaffolds.
Building brains
One session at the meeting dealt with the challenges of studying
human brain development in vitro. A common theme from these
talks was the need for systems to study human-specific aspects of
brain development (particularly cortical development), including
differences in brain size and complexity. Although the mouse
remains a powerful model system, it differs in several important
aspects from human, in a manner that is clinically important when
studying neurodevelopmental disorders.
Arnold Kriegstein (University of California San Francisco, USA)
discussed how he and his colleagues have approached the problem
of how to carry out mechanistic studies of human brain development
by using explant culture to analyse the complexity of human stem
and progenitor types in the developing neocortex. Using a labelling
strategy, they have thoroughly characterised the proliferation and
cell division kinetics of different types of cerebral cortex progenitor
cells by live imaging in this ex vivo system (Ostrem et al., 2014).
Rick Livesey (University of Cambridge, UK) described his lab’s use
of directed differentiation of human PSCs to replay forebrain
neurogenesis for comparative studies of human and non-human
primate brain development. Jürgen Knoblich (Institute of Molecular
Biotechnology, Vienna, Austria) presented recent advances using
organoids/embryoid bodies generated from iPSCs to study brain
development in 3D culture (Lancaster et al., 2013). In this system,
he and his colleagues have observed the development of multiple
brain regions over several months, including the retina, cerebral
cortex and ventral forebrain. He reported exciting applications of
this system to study the role of spindle orientation in neurogenesis,
using genome engineering for targeted knockout of genes of
interest.
Muscle and fat cells
In addition to the talks that centred on the haematopoietic and
nervous systems, a recurring theme of the meeting was how to
exploit developmental principles to replay development for the
production of defined cell types. For example, Olivier Pourquié
(Harvard Medical School, Boston, USA) discussed his lab’s
development of a successful strategy for differentiation of mouse
and human ESCs into skeletal muscle cells. Using their
understanding of muscle development, they recapitulated
successive stages differentiation in vitro to generate paraxial
mesoderm and ultimately contractile skeletal muscle fibres.
Remarkably, these cultures also developed satellite cells. Sanjay
Sinha (University of Cambridge, UK) focused on vascular smooth
muscle cells (SMCs), which originate from three different
compartments of the embryo. Using defined chemical culture
conditions based on their knowledge of development, he modelled
development of the three principal types of SMCs from human
iPSCs and ESCs, and used this to model several aspects of the
pathogenesis of the developmental disorder Marfan syndrome.
Christian Dani (Institute of Biology Valrose, Nice, France)
described two types of adipocytes that co-exist in human: brown
adipocytes that spend energy, generate heat and are abundant in
babies but remain mainly in deep organs in adults; and white
adipocytes that store energy and are associated with obesity. Human
iPSCs can generate both types of adipocytes in a lengthy protocol
but with low efficiency. Dani’s lab has used a variety of approaches
to optimise brown and white adipocyte production from iPSCs
(Mohsen-Kanson et al., 2014).
Back in an in vivo system, Benoit Bruneau’s lab (Gladstone
Institute of Cardiovascular Disease, San Francisco, USA) has
mapped the origin of heart compartments in the developing mouse
embryo using complex lineage analyses. A major finding from their
work is that there are no common precursors that give rise to left and
right ventricles (Devine et al., 2014). They are now applying this
work to disease modelling of human cardiac developmental
disorders.
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Islet cells in health and disease
Given the increasing incidence of diabetes mellitus worldwide,
there has been a good deal of attention paid to the challenges of
creating human endocrine and exocrine pancreatic tissue in vitro.
Danwei Huangfu (Memorial Sloan Kettering Cancer Center,
New York, USA) introduced a powerful CRISPR/Cas9-based
system that enables fast concurrent mutation of several genes
(González et al., 2014), a system she is using for studying the
functions of multiple genes in islet cell development. Ray Dunn
(Institute of Medical Biology, Singapore) has focused on the
regulation of the transcription factor PDX1, essential for pancreas
development, as a way to understand the mechanisms controlling
pancreatic specification. In a human ESC differentiation model,
his lab has found that PDX1might both promote expression of a
pancreas-specific genetic program and suppress liver-specific
genes, through cooperation with co-factors. Henrik Semb
(University of Copenhagen, Denmark) reported on his group’s
studies of pancreas organogenesis in vivo (in mouse) and asked
whether tissue architecture governs cell fate decisions. To this end,
he has explored the roles of the small GTPases Cdc42, RhoA or
Rac1, which are involved in actin polymerisation, cell movement
and epithelial cell polarisation. Genetic manipulation of these
genes enabled shifts to various pancreatic exocrine and endocrine
cell phenotypes: acinar, ductal and endocrine (Kesavan et al.,
2014). His lab is delineating the cellular pathways involved, as a
means to better control human islet cell production from ESCs
and iPSCs.
From 2D to 3D: human development in the round
Although there is a good deal of effort in a number of fields to
generate specific, individual cell types from PSCs (as discussed
above), a related challenge is harnessing developmental biology to
generate complex cell assemblies, tissues and organs. A number of
talks, including that of Jürgen Knoblich mentioned above, dealt
with the problem of generating 3D human tissues.
Hiro Nakauchi (Stanford University, USA, and University of
Tokyo, Japan) focused on the generation of entire organs in vivo
from iPSCs by blastocyst complementation to generate chimeras.
Using Pdx1-null mice, which completely lack a pancreas, he
successfully generated a normal adult pancreas by injecting wild-
type cells into the mutant blastocyst. Importantly, this was effective
between species: mouse ESCs successfully integrated and
differentiated in the rat and vice versa, providing proof-of-
principle that inter-specific chimeras are feasible (Kobayashi
et al., 2010). Interestingly, the size of the chimeric organ
corresponded to size of the host species. Thus, if we want to
generate human organs we should choose a host animal of
appropriate size. Nakauchi went on to describe pioneering work
his lab is doing in pig (Matsunari et al., 2013) to create human
organs in non-human species. To address the ethical concerns over
neural and gamete contribution, his team developed a method of
‘targeted organ generation’. By conditional expression of Mixl1
during the first phase of embryonic development, they could direct
differentiation of PSC-derived cells selectively toward the
endodermal lineage (Kobayashi et al., 2014).
A number of talks approached the problem of organogenesis
ex vivo. Hans Snoeck (Columbia University, New York, USA) aims
to generate airway epithelia and complete airways from human
PSCs. He reported a number of studies in which he and his
colleagues have generated different parts of the human respiratory
system in vitro (Huang et al., 2014), including recapitulating
branching morphogenesis of alveoli. Clare Blackburn (MRC Centre
for Regenerative Medicine, Edinburgh, UK) described her lab’s
work on thymus development and regeneration. They found that
overexpression of a single transcription factor, Foxn1, in a mouse
model is sufficient to increase the regeneration and juvenilisation of
the thymus, through expansion of thymic epithelium progenitors
(Bredenkamp et al., 2014a). Furthermore, overexpression of Foxn1
in mouse embryonic fibroblasts in culture was sufficient to convert
them into thymic epithelium that, when grafted under the kidney
capsule in combination with foetal thymus mesenchyme, could
build a thymus capable of maintaining lymphoid differentiation in
nude mice (Bredenkamp et al., 2014b).
Finally, JimWells (Cincinnati Children’sHospitalMedical Center,
USA) described a series of experiments on the differentiation of
human PSCs into 3D organoids of different regions of the
gastrointestinal tract (McCracken et al., 2014). Their operating
principle is to control early embryonic morphogenesis by
manipulating signalling pathways that are known from embryonic
development to induce definitive endoderm and subsequently gut
tube morphogenesis. Manipulation of extracellular signalling
promotes further specialisation into specific organoids of different
regions of the gastrointestinal tract. Transplantation of such organoids
under the kidney capsule of immunocompromised mice results in the
formation of tissues with mature gut architecture, including the
various muscle and epithelial layers (Watson et al., 2014). These
organoids are now being used for studying a number of gut diseases.
Concluding remarks
The main theme to emerge from this meeting was the striking
advances that have been made in using mouse and human stem
cell systems to study human development in health and disease.
The field has clearly advanced a great deal from the early days of
the production of individual cell types. The potential of stem cell
systems, combined with genome engineering and the information
emerging from the different genome projects, is beginning to be
realised. Current applications range from mechanistic studies of
human development, to disease modelling and tissue engineering.
The participants left the meeting energised about the possibilities
for the field and committed to establishing a biannual meeting
to share progress and findings in what is a fast-moving area.
The meeting closed, as it began, with an acknowledgement of
Yoshiki Sasai’s legacy, and the meeting was dedicated to his
memory.
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